NeuroLogica Corporation recalls GM60A. Digital Diagnostic Mobile X-Ray System.
- Recall date
- July 8, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2715-2024
- FDA classification
- Class II
- Brand / firm
- NeuroLogica Corporation
- Sold / distributed
- US Nationwide distribution in the states of AR, CT, GA, IN, KS, MA, MD, MO, MS, NC, ND, NJ, NV, OH, PA, VA, WV & DC.
Why it was recalled
Potential for the anti-fall system of the device arm to fail.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
GM60A. Digital Diagnostic Mobile X-Ray System.
Get recall alerts
Free email alert whenever NeuroLogica Corporation has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: NeuroLogica Corporation